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Abstract
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We report an approach to the in situ synthesis of oligonucleotide arrays on surfaces coated with
crosslinked polymer multilayers. Our approach makes use of methods for the ‘reactive’ layer-bylayer assembly of thin, amine-reactive multilayers using branched polyethyleneimine (PEI) and
the azlactone-functionalized polymer poly(2-vinyl–4,4’-dimethylazlactone) (PVDMA). Postfabrication treatment of film-coated glass substrates with D-glucamine or 4-amino-1-butanol
yielded hydroxyl-functionalized films suitable for the Maskless Array Synthesis (MAS) of
oligonucleotide arrays. Glucamine-functionalized films yielded arrays of oligonucleotides with
fluorescence intensities and signal-to-noise ratios (after hybridization with fluorescently labeled
complementary strands) comparable to those of arrays fabricated on conventional silanized glass
substrates. These arrays could be exposed to multiple hybridization-dehybridization cycles with
only moderate loss of hybridization density. The versatility of the layer-by-layer approach also
permitted synthesis directly on thin sheets of film-coated poly(ethylene terephthalate) (PET) to
yield flexible oligonucleotide arrays that could be readily manipulated (e.g., bent) and cut into
smaller arrays. To our knowledge, this work presents the first use of polymer multilayers as a
substrate for the multi-step synthesis of complex molecules. Our results demonstrate that these
films are robust and able to withstand the ~450 individual chemical processing steps associated
with MAS (as well as manipulations required to hybridize, image, and dehybridize the arrays)
without large-scale cracking, peeling, or delamination of the thin films. The combination of layerby-layer assembly and MAS provides a means of fabricating functional oligonucleotide arrays on
a range of different materials and substrates. This approach may also prove useful for the
fabrication of supports for the solid-phase synthesis and screening of other macromolecular or
small-molecule agents.
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Array-based methods for solid-phase synthesis—in which large numbers of molecules are
synthesized directly on a solid support in a spatially patterned and/or addressable manner—
are broadly useful because the resulting arrayed compound libraries are well-suited for highthroughout screening in a parallel and multiplexed manner.1–5 Approaches to solid-phase
synthesis and screening are now well-established and are used extensively for the fabrication
of DNA microarrays used in genome-wide studies to (i) identify and/or quantify RNA
transcripts present under different experimental conditions,6 (ii) identify DNA modifications
such as methylated bases,7 and (iii) monitor DNA-protein interactions.8 The in situ synthesis
of oligonucleotides on appropriately functionalized planar substrates can be used to fabricate
high-density arrays composed of large libraries of oligonucleotides (e.g., with densities
greater than 100,000 features/cm2).9–11 In comparison to methods for the immobilization or
‘spotting’ of arrays of pre-synthesized oligonucleotides on surfaces,12,13 in situ synthesis has
the general advantage that each individual oligonucleotide feature can be synthesized
directly, in parallel, and in a base-by-base manner.14 Phosphoramidite-based
chemistries15,16 are widely used for this purpose and permit the synthesis of immobilized
sequences as long as ~150 bases in length in either a random or a directed manner (i.e., as nmers of all possible base combinations or as n-mers of a specific base sequence).17
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The types of chemical reactions and environments used during in situ synthesis often restrict
the types of substrates that can be used for array fabrication. In many approaches to the
synthesis of oligonucleotide arrays, for example, substrates are exposed repeatedly to
organic solvents, ultraviolet light, oxidizing agents, etc. An additional design requirement
specific to the development of substrates for use with phosphoramidite chemistry is the need
for free hydroxyl groups on the surface of a substrate to enable coupling of the first
nucleoside phosphoramidite. Finally, in addition to stability during synthesis, substrates
should also, ideally, be able to withstand exposure to the range of solvents, reagents, and
other physical/mechanical challenges associated with downstream use of the arrays (e.g., in
subsequent biochemical/screening assays, etc.). A number of approaches have been
developed to functionalize the surfaces of glass,18 nanocrystalline diamond,18,19 and
amorphous carbon20,21 substrates with terminal hydroxyl groups to permit in situ synthesis,
improve array performance, and address other issues that can arise during subsequent
studies.
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The work reported here was motivated by our interests in the design of reactive, polymerbased interfaces22–27 and expanding the range of substrates that are compatible with in situ
oligonucleotide synthesis.18,28–30 Polymer-based substrates could present attractive
alternatives to glass and carbon-based substrates used in past studies because they are low
cost, durable, and easily processed. Approaches based on polymer thin films could also be
attractive because they can often be used to functionalize the surfaces of non-planar (i.e.,
curved) objects and porous/flexible substrates that could provide practical advantages during
synthesis or subsequent screening. One drawback common to many conventional polymerbased materials, however, is that they can exhibit poor resistance to organic solvents
commonly used during synthetic reactions (e.g., they either dissolve or swell upon
prolonged exposure). Conversely, many of the more chemically- and mechanically stable
polymer-based materials are, inherently, more resistant to facile chemical functionalization.
Here, we report a step toward the design of polymer-based thin films as substrates for the in
situ synthesis of oligonucleotide arrays. Our approach is based on methods developed for the
‘layer-by-layer’ fabrication of polymer thin films on surfaces.
Methods for the layer-by-layer assembly of polymer thin films31 provide precise (and often
nanometer-scale) control over the chemical composition, surface chemistry, and physical/
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mechanical properties of thin films fabricated from a broad range of materials.32–35 This
approach does not involve high-temperature processing steps and is also well suited for the
fabrication of thin, conformal films on the surfaces of objects with complex surface features.
In comparison to polyelectrolyte-based multilayers stabilized by weak interactions (e.g.,
ionic or hydrogen-bonding interactions)31,35–37 that can be disrupted under a variety of
conditions, covalently cross-linked multilayers can exhibit increased stability in both organic
and aqueous environments. Covalently crosslinked multilayers can be fabricated either by (i)
post-fabrication crosslinking of pre-assembled multilayers (e.g., by treatment with chemical
crosslinking agents),38–42 or (ii) by direct layer-by-layer deposition of mutually reactive
polymers.43–47
Our group recently reported a ‘reactive’ approach to the layer-by-layer fabrication of
crosslinked multilayers that exploits reactions between amine-reactive, azlactonefunctionalized polymers [e.g., poly(2-vinyl-4,4-dimethylazlactone) (PVDMA)] and primary
amine-containing polymers [e.g., poly(ethylene imine) (PEI)] (Figure 1).In addition to
providing a convenient route for the design of covalently-crosslinked thin (and ultrathin)
films, this reactive approach (Figure 1C) yields films containing residual, amine-reactive
azlactone groups that can be used to introduce additional chemical or biological
functionality to film-coated surfaces (e.g., by simple post-fabrication treatment with a range
of different amine-functionalized agents; see Figure 1D).22,24,25,27,48
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In this paper, we demonstrate that these crosslinked and reactive thin films can be used as
platforms for in situ solid-phase synthesis and array-based screening. We demonstrate that
hydroxyl-functionalized multilayers fabricated from PEI and PVDMA (referred to hereafter
as PEI/PVDMA films) are compatible with phosphoramidite chemistry and the range of
chemical and photochemical conditions encountered during the in situ, base-by-base
maskless array synthesis (MAS) of oligonucleotide microarrays (Figure 1E).10,49 This
approach can be used to fabricate stable and reusable oligonucleotide arrays on the surfaces
of rigid planar substrates (e.g., on film-coated glass slides) and on the surfaces of flexible
polymer-based substrates [e.g., on thin sheets of poly(ethylene terephthalate) (PET)]. We
note here that the fabrication of DNA microarrays on surfaces coated with conventional,
polyelectrolyte-based multilayers (PEMs) by the printing of pre-synthesized oligonucleotide
sequences has been reported previously.50 To the best of our knowledge, however, this
current report is the first demonstration of the in situ and multi-step synthesis of arrays of
complex molecules on multilayer-coated surfaces.

Materials and Methods
NIH-PA Author Manuscript

Materials
Branched poly(ethylene imine) (PEI; MW ~25,000), reagent grade solvents, and all
chemicals used were purchased from Sigma Aldrich (Milwaukee, WI) and used without
further purification, unless otherwise noted. 2-Vinyl-4,4-dimethylazlactone (VDMA) was a
kind gift from Dr. Steven M. Heilmann (3M Corporation, Minneapolis, MN). Poly(2vinyl-4,4-dimethylazlactone) (PVDMA; MW = 20,400; PDI = 3.3) was synthesized as
described previously.25 Thin sheets of PET film (0.004 inches thick) were purchased from
McMaster Carr. Compressed air used in all drying steps was filtered through a 0.2 µm
membrane syringe filter to remove particulates.
Substrate Preparation
Glass and poly(ethylene terephthalate) (PET) substrates were cut to dimensions (25 mm ×
35 mm) suitable for MAS oligonucleotide array synthesis. Prior to the fabrication of PEI/
PVDMA multilayers, each substrate was prepared as follows: Glass slides were first
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Fabrication and Functionalization of PEI/PVDMA Multilayers
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silanized in a 1% (v/v) solution of (3-aminopropyl)triethoxysilane (APTES) in anhydrous
toluene for 1 hour. The slides were then rinsed with ~10 ml of toluene and ~10 ml of ethanol
and heat cured for 1 hour at 100 °C. PET films were rinsed with methanol, dried under a
stream of compressed air, and placed in a solution of PEI (1 mg/ml in methanol) overnight at
37 °C prior to use. Hydroxyl-terminated glass slides, used as references for oligonucleotide
array fabrication, were modified with N-(3-triethoxysilylpropyl)-4-hydroxy-butyramide, as
described previously.18

Synthesis of Oligonucleotide Arrays

PEI/PVDMA multilayers were fabricated on glass and PET substrates using the following
general procedure: (i) substrates were submerged in a solution of PVDMA (20 mM in
acetone with respect to the polymer repeat unit) for 30 s; (ii) substrates were removed and
immersed in an acetone bath for 15 s and then rinsed with ~10 ml of acetone; (iii) substrates
were submerged in a solution of PEI (20 mM in acetone with respect to the polymer repeat
unit) for 30 s; and (iv) substrates were removed and rinsed again using the procedure
outlined under step (ii). This cycle was repeated four times to fabricate multilayers
consisting of 4 PEI/PVDMA layer pairs (referred to hereafter as ‘bilayers’). A final layer of
PVDMA was then deposited (using steps (i) and (ii) of the above procedure) to provide
additional reactive azlactone groups on the top surface of the film. Films having this general
structure are referred to hereafter as being 4.5 bilayers thick. The multilayers were washed
with ~25 ml of acetone and then dried under a stream of compressed air. These films were
functionalized with D-glucamine or 4-amino-1-butanol by incubating film-coated substrates
in solutions of either molecule (110 or 200 mM, respectively) in DMSO for 1 hour.22,24
These functionalized films were then rinsed with DMSO, methanol, and RO water (~25 ml
of each) and dried under a stream of compressed air.

Each oligonucleotide array was synthesized directly on hydroxyl-terminated PEI/PVDMA
film-coated substrates using a previously described ultraviolet light-directed
photolithographic method known as Maskless Array Synthesis (MAS).10 Briefly, individual
oligonucleotide sequences were synthesized, in a base-by-base manner, directly on the
multilayers using 3’-nitrophenylpropyloxycarbonyl (NPPOC)-protected nucleosides and a
digital micromirror-based Biological Exposure and Synthesis System (BESS) connected to a
Perseptive Biosystems Expedite Nucleic Acid Synthesis System. Table 1 summarizes the
oligonucleotide sequences used in this work. Probes 1 and 2 (19 and 23 nt, respectively)
were separated from the surface by a 10 thymidine (dT) spacer. This length of spacer has
been shown in past studies to increase hybridization efficiency.51

NIH-PA Author Manuscript

Characterization and Analysis of Oligonucleotide Arrays
Fluorescently labeled complementary oligonucleotide sequences (Complements 1 and 2,
Table 1) were synthesized by Integrated DNA Technologies (Coralville, IA) with a 3’fluorescein (36-FAM) or a 3’-Cy3 (3Cy3Sp) moiety. Oligonucleotide arrays synthesized on
PEI/PVDMA multilayers were hybridized by placing 40 µl of 1X SSPE buffer containing
the complementary oligonucleotide(s) (2 µM total oligonucleotide concentration, 1X SSPE
buffer contains 150 mM NaCl, 10 mM Na2HPO4, and 1 mM EDTA, pH = 7.4) on the
surface, covering the surface with a glass cover slip to ensure the liquid was equally spread
across the surface, and then incubating the array for 30 minutes at room temperature in a
humid chamber. Nonspecifically bound complementary oligonucleotides were removed
from the surface by placing 100 µl of 1X SSPE buffer on the surface and incubating the
array for 5 minutes at 37 °C in a humid chamber, and then rinsing the surface with
approximately 10 ml of 1X SSPE buffer. Fluorescence images of the hybridized arrays were
acquired using a GeneTAC UC 4×4 scanner (Genomic Solutions). To keep the hybridized
Chem Mater. Author manuscript; available in PMC 2013 March 13.
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arrays wet while fluorescence images were acquired, 20 µl of 1X SSPE buffer was placed on
the array and a cover slip was applied to provide a uniform layer of buffer covering the
surface. Excess liquid was removed before imaging.
The hybridization density of each array (i.e., the density of oligonucleotides on the surface
that are accessible for hybridization with complement, under the above hybridization
conditions) was determined using a previously reported wash-off method.52,53 Each array
was hybridized with fluorescein-labeled complements (Table 1), the nonspecifically bound
oligonucleotides were removed, and the array was then dehybridized in 2 ml of 8 M urea.
The fluorescence intensity of the urea solution was compared to a calibration curve (10−11 to
10−8 M) of the fluorescein-labeled complement in 8 M urea, and the hybridization densities
were calculated.
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The stability of the oligonucleotide arrays synthesized on film-coated substrates was
determined over five consecutive hybridization and dehybridization cycles. Each array was
hybridized with fluorescently labeled complement and a fluorescence image was obtained,
as described above. The arrays were dehybridized by placing 250 µL of 8 M urea onto the
array, incubating the array for 30 minutes at room temperature in a humid chamber, and then
rinsing with ~25 ml of RO water. Fluorescence images of the dehybridized arrays were
acquired to verify that the complementary oligonucleotides were removed from the surface.
This general procedure was repeated up to five times (see text). The values reported in this
work are averages from n = 3 arrays, unless otherwise noted.

Results and Discussion
Fabrication and Functionalization of Reactive Multilayers
Glass substrates coated with reactive PEI/PVDMA multilayers were fabricated using a
layer-by-layer procedure (Figure 1C) optimized previously for the fabrication of these
materials on glass and silicon substrates.22 For all experiments described below, we used
glass silanized with APTES, a primary amine-containing silane reagent, to improve adhesion
of the multilayers to the underlying substrate and prevent delamination during
oligonucleotide synthesis. Films were fabricated by the sequential deposition of 4.5 layer
pairs (or ‘bilayers’) of PEI and PVDMA (see Materials and Methods for additional details
related to film fabrication). Otherwise identical films fabricated on reflective silicon
substrates exhibited linear film growth profiles and were ~35 nm thick, as determined using
ellipsometry. These results are consistent with those of our past studies.22
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After deposition, PEI/PVDMA films were treated with solutions of D-glucamine or 4amino-1-butanol (structures shown in Figure 1B) to immobilize terminal hydroxyl groups
required for phosphoramidite-based oligonucleotide array synthesis (Figure 1). 4-Amino-1butanol was selected because it is similar in structure to motifs used previously to
functionalize substrates for MAS;18,28 glucamine was selected on the basis of our past
studies on the functionalization of PEI/PVDMA films.24,27 In that work it was demonstrated
that treatment of PEI/PVDMA films with solutions of glucamine for one hour is sufficient to
react exhaustively with residual azlactone functionality (as determined by FTIR
spectroscopy) and immobilize the hydroxyl functionality (or other groups).24 These past
studies also revealed that glucamine and other amine-based agents immobilized in this
manner are accessible at the surfaces of the treated films (e.g., as evidenced by large
changes in water contact angles of treated films, etc.).22,24,26,27 We note, however, that this
treatment procedure likely also results in the installation of hydroxyl functionality in the
interior (i.e., the lower layers) of these films, and that these additional hydroxyl groups
could also react with phosphoramidite monomers during oligonucleotide synthesis. We
return below to a discussion of this possibility.
Chem Mater. Author manuscript; available in PMC 2013 March 13.
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Oligonucleotide arrays were in situ synthesized on hydroxyl-functionalized films in a baseby-base manner using 3’-nitrophenylpropyloxycarbonyl (NPPOC)-protected nucleosides
and a Maskless Array Synthesizer (see Materials and Methods and reference 18 for
additional details). Table 1 shows the sequences of the two different oligonucleotides
(Probes 1 and 2) used in this study. Control arrays were also synthesized on hydroxylterminated (uncoated) glass substrates, the conventional substrate used for this application,18
to provide a direct comparison to established methods and materials. We note here that each
iterative cycle of MAS (during which a single new nucleoside is added) exposes the solidphase substrate to multiple different chemical processing steps (including flowing and static
exposure to different organic and drying media, exposure to activator or base pair solutions,
photo-irradiation steps, and oxidation procedures).18 The complete multi-step synthesis of
the oligonucleotide arrays used in the studies described below thus requires the exposure of
a surface to ~450 individual (albeit iterative) chemical processing steps. The fabricated
arrays were then hybridized with fluorescently labeled complementary oligonucleotides and
imaged using a fluorescence scanner to characterize both the fidelity of patterning and the
ability of the immobilized sequences to pair with complementary oligonucleotide sequences.
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We performed an initial series of MAS experiments to evaluate the suitability of glucamineand 4-amino-butanol-treated PEI/PVDMA films as substrates for the in situ synthesis of
arbitrary, but well-defined, patterns of oligonucleotides. Figure 2 shows images of a
glucamine-treated film (Figure 2A) and a 4-amino-1-butanol-treated film (Figure 2B)
presenting patterns of Probe 2 (hybridized with Cy3-modified Complement 2 prior to
imaging). The large areas of uniform red fluorescence in these images (scales are in
millimeters) provide visual evidence that the thin, crosslinked multilayer films do not peel or
delaminate significantly under the conditions used during synthesis (or during subsequent
hybridization and imaging). Visual inspection of these images also reveals that levels of
non-specific, background adsorption of Complement 2 are significantly higher on 4amino-1-butanol-functionalized films than for arrays fabricated on glucamine-functionalized
films [that is, areas not patterned with Probe 2 during MAS appear dark on the glucaminetreated film (2A), but significant levels of red fluorescence are observed in these same
locations on the 4-amino-1-butanol-treated film (2B)].
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We next fabricated oligonucleotide arrays containing checkered patterns of square-shaped
features of Probes 1 and 2 on each substrate (individual features are 144 × 144 µm in size).
Figure 2C shows a representative image of an array [hybridized with fluorescein-modified
Complement 1 (shown in green) and Cy3-modified Complement 2 (shown in red) prior to
imaging] synthesized on a glucamine-treated film. The average fluorescence intensities were
measured, and the average signal-to-noise values for both the fluorescein and Cy3
containing complements were determined using Eqn 1. The background signal is defined
here as any area of the array that does not contain a feature of interest (i.e., the background
for fluorescein-containing features includes all areas of the array that contain no
oligonucleotides and all features of the array that were hybridized with Cy3 Complement
2).28 Table 2 summarizes the average fluorescence intensities and signal-to-noise values for
the checkered pattern oligonucleotide arrays synthesized on film-coated glass substrates and
control silanized (uncoated) glass substrates. The values reported in Table 2 are the average
values collected from three separate arrays. Arrays on substrates functionalized using 4amino-1-butanol resulted in higher fluorescence background intensities for both fluorescein
and Cy3 modified complements, indicating a higher amount of non-specific adsorption of
oligonucleotides to the surfaces of these films as compared to arrays fabricated on
glucamine-functionalized films.

Chem Mater. Author manuscript; available in PMC 2013 March 13.
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The hybridization density (i.e., the number of oligonucleotides on the surface of the films
accessible for hybridization per cm2) for each of the oligonucleotide arrays used above was
also determined (Table 2). Each array was hybridized with fluorescein-modified
complement, rinsed to remove non-specifically adsorbed oligonucleotides, and then
dehybridized in a known volume of 8 M urea.52,53 The urea solutions were collected and
their fluorescence intensities were compared to a calibration of known concentrations of the
fluorescein-modified oligonucleotide in 8 M urea. The hybridization densities measured for
the silanized glass substrates (1.45 ± 0.39 × 1012 oligonucleotides/cm2) were comparable to
those previously reported in the literature.18,28 The hybridization densities for arrays
synthesized on both glucamine and 4-amino-1-butanol functionalized films were comparable
to those of arrays synthesized on silanized glass (although the signal-to-noise ratios were
higher for 4-amino-1-butanol functionalized films, as described above).
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We note again that the presence of hydroxyl functionality in the bulk of the films (i.e., in the
layers below the surface) could also lead to the synthesis of ‘buried’ oligonucleotides (or
short fragments of oligonucleotides) in the interiors of these films. While our current results
do not establish the extent to which this occurs, it is unlikely that such buried sequences
would be readily accessible to the complement strands used in the hybridization assays
described above. We therefore interpret the hybridization densities of the arrays on filmcoated substrates shown in Table 2 to reflect the density of immobilized oligonucleotide
present and accessible at or near the topmost surfaces of these films.
Characterization of Oligonucleotide Array Stability
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We conducted a series of experiments to characterize the ability of arrays synthesized on
film-coated substrates to withstand the chemical and mechanical challenges associated with
repeated hybridization/dehybridization cycles. Physically and chemically stable substrates
enable the reuse of arrays,18,28 and can both alleviate the cost of obtaining multiple highdensity arrays and allow multiple different experiments to be performed using a single array
(e.g., to eliminate concerns associated with array-to-array variation).54 The stability of
oligonucleotide arrays synthesized on glucamine-functionalized films was compared to the
stability of arrays fabricated on silanized glass. Fluorescence intensity images of the arrays
(and corresponding signal-to-noise ratios) were used to characterize the stability of
oligonucleotide arrays exposed to a series of five hybridization/dehybridization cycles.
Figure 3 shows the average fluorescence intensity of Cy3-containing features as a function
of hybridization cycle. Fluorescence intensity images were also acquired after each
dehybridization procedure to verify that all of the oligonucleotides were removed from the
surface.
As shown in Figure 3, the fluorescence intensity of arrays synthesized on glucamine-treated
films was relatively constant over the first three hybridization/dehybridization cycles. These
arrays, however, lost 22% of their initial fluorescence intensities by the fifth hybridization
(arrays on silanized glass substrates retained their initial fluorescence intensity). This loss of
fluorescence intensity correlates with a decrease in the hybridization density of the surface
(or the number of oligonucleotides accessible for hybridization) and could result from (i) a
decrease in the number of oligonucleotides that remain attached to the surface or (ii)
changes in interactions between the oligonucleotides and the film surface (e.g., during
dehybridization steps) that restrict their accessibility during subsequent re-hybridization.
With respect to this first possibility, we note that the treatment of our azlactone-containing
Chem Mater. Author manuscript; available in PMC 2013 March 13.
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films with glucamine results in the immobilization of glucamine through the formation of an
amide/amide linkage55 (Figure 1D) that should be hydrolytically stable under the conditions
encountered during the hybridization/rehybridization conditions used here.
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Decreases in oligonucleotide density over multiple dehybridization cycles could also result
from the loss or leaching of small numbers of oligonucleotide-functionalized polymer chains
that are physically entrapped (as opposed to covalently crosslinked) in the topmost layers of
a film. We note, however, that images of these rehybridized films did not reveal changes in
the individual features of these arrays (e.g., feature broadening or blurred edges) that would
also be expected to result from the lateral diffusion of free polymer chains (data not shown).
We also did not observe large-scale physical delamination of films during any of these
experiments (e.g., by optical or fluorescence microscopy), and such delamination would be
more likely to result in complete, rather than gradual, loss of signal as observed here.
Finally, as outlined above, the decreases in fluorescence intensity shown in Figure 3 could
also result from changes in the extent to which surface-bound oligonucleotides are
physically accessible after multiple treatment cycles. For example, repeated chemical and
physical manipulation of these films could result in the exposure of segments of PEI
(present in underlying layers of the films) that could interact with and sequester negatively
charged oligonucleotides through ionic interactions. Additional characterization will be
necessary to understand the extent to which such changes could occur in these experiments.
In the context of this current study, however, we conclude that arrays fabricated on these
film-coated substrates are stable and robust, and that they can be reused for at least three
hybridization/rehybridization cycles without significant deterioration of signal.
Fabrication of Oligonucleotide Arrays on Flexible Polymer Sheets
One potential practical advantage of the layer-by-layer approach to film-fabrication used
here is that it can be used to deposit thin, amine-reactive films on a broad range of substrate
materials, including objects with complex surface features and a range of physical/
mechanical properties.25,27 We sought to determine whether the approach used above to
fabricate arrays on film-coated glass substrates could be used to synthesize functional arrays
on the surfaces of soft/flexible substrates. Arrays of molecules synthesized on soft, flexible,
and topographically complex or patterned substrates could offer practical advantages over
traditional arrays fabricated on rigid substrates, including the potential for new assay
formats. Arrays fabricated on soft substrates can also be cut or separated into smaller pieces
using simple laboratory equipment (e.g., a razor blade or dissection scalpel) more easily than
arrays fabricated on glass, silicon, or carbon substrates and could thus offer advantages from
both manufacturing/processing and point-of-use perspectives.
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To investigate the feasibility of this approach, we performed a series of experiments using
thin sheets of flexible PET as a model transparent polymer substrate. PEI/PVDMA films
were fabricated on PET sheets and then functionalized by treatment with glucamine using
procedures identical to those described above for the preparation of film-coated glass
substrates (see Materials and Methods for additional details related to preparation of PET
substrates). Figure 4a shows images of four oligonucleotide arrays synthesized, in a
checkered pattern of Probes 1 and 2, on a film-coated PET substrate. The hybridization
densities for these arrays were similar to those measured for arrays synthesized on filmcoated glass substrates (Table 2), but the average signal-to-noise ratio was approximately 2fold lower. The stability of the PET arrays upon multiple hybridization/dehybridization
cycles was comparable to that of their film-coated glass analogs (Figure 3b) with an average
fluorescence intensity loss of 30 ± 6% after five hybridizations (as compared to the 22 ± 3%
average fluorescence intensity loss for arrays on film-coated glass).

Chem Mater. Author manuscript; available in PMC 2013 March 13.
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The flexible nature of the underlying PET films did not have an apparent influence on the
fluorescence intensities or the average signal-to-noise ratios of the hybridized
oligonucleotide features. We performed two experiments to investigate the possible
influence of substrate flexing either before or after hybridization. In the first experiment, a
PET array was hybridized, a fluorescence image was obtained, and the curvature of the
hybridized array was temporarily altered by manual bending of the substrate for one minute
(each substrate was flexed such that the opposite ends of the surface were brought in
contact, but a crease was not formed). No difference in the average fluorescence intensity or
signal-to-noise ratio was observed as a result of bending. In a second set of experiments, we
compared properties of PET arrays that were not bent prior to hybridization to those of
arrays that were bent prior to use. The hybridization densities, average fluorescence
intensities, and signal-to-noise ratios for arrays subjected to these treatments were
statistically indistinguishable (data not shown). While we did not characterize the effects of
flexing these array substrates surface during hybridization, several reports suggest that the
curvature of an array surface can influence the density of hybridization.56,57 The ability to
deposit PEI/PVDMA multilayers on a variety of different soft and flexible substrates could
thus provide new tools to investigate the effects of curvature and dynamic flexing on
hybridization.
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Figure 4b shows a section of the oligonucleotide array shown in Figure 4a that was cut and
separated from the original array using a razor blade. For this experiment, the intact array
was (i) hybridized and imaged (Figure 4a), (ii) dehybridized in 8 M urea, (iii) physically cut
in half, and then (iv) rehybridized and imaged again (Figure 4b). The signal-to-noise ratio
for this smaller section of the array decreased marginally after cutting the substrate into
pieces (e.g., a signal-to-noise decrease from 59 to 51 for the Cy3-containing features). We
attribute these small increases in background fluorescence, at least in part, to difficulties
associated with keeping the hybridized arrays on these cut substrates wet during imaging.
(Each fluorescence image was acquired by wetting the array with 1X SSPE buffer and then
placing a microscope cover slip over the array to evenly disperse the water across the
surface and keep the array wet, as used in the studies described above on glass substrates.
Roughness at the edges of the cut arrays used in these experiments, however, made it more
difficult to maintain uniform contact with the cover slips and resulted in higher background
fluorescence intensity signals.) We did not observe significant peeling, delamination, or
large-scale cracking of oligonucleotide arrays fabricated on film-coated PET during
synthesis or as a result of any of the physical manipulations (e.g., cutting or bending)
described above.
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We used PET in this study as a model transparent/flexible polymer substrate to demonstrate
proof-of-concept. In a broader context, however, the ability to fabricate PEI/PVDMA
multilayers on a wide variety of other types of substrates (including inorganic and organic
surfaces, ‘hard’ and ‘soft’ materials, and chemically/topographically patterned
substrates)22,25,27,58,59 could permit the solid phase synthesis of libraries of both large and
small molecules in new formats and enable the development of new approaches to
compound screening. In particular, we have demonstrated in past studies that functionalized
PEI/PVDMA films can be removed from the substrates on which they were fabricated to
produce free-standing films that can be transferred readily to the surfaces of other objects.48
In combination with new approaches to on-film synthesis, this multilayer-based approach
could thus be used to transfer arrays of molecules onto substrates, or to install them in
locations, that are otherwise difficult (or impossible) to use with MAS or other methods of
synthesis.
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We have reported an approach to the in situ synthesis of oligonucleotide arrays on surfaces
coated with covalently crosslinked polymer multilayers. Our results demonstrate that aminereactive PEI/PDVMA multilayers can be functionalized with hydroxyl-containing molecules
suitable for the phosphoramidite-based Maskless Array Synthesis (MAS) of
oligonucleotides. Film-coated glass substrates treated with D-glucamine yielded arrays of
model oligonucleotide probes with average fluorescence intensities and signal-to-noise
ratios (after hybridization with fluorescently labeled complement strands) that were
comparable to those of arrays fabricated on conventional hydroxyl-terminated silanized
glass substrates. The versatility of the layer-by-layer approach used to fabricate PEI/
PVDMA multilayers also permitted the synthesis of oligonucleotide arrays directly on thin
bulk sheets of polymer (e.g., PET). The ability to fabricate multilayers on the surfaces of
soft and flexible substrates creates opportunities for post-fabrication processing (e.g.,
cutting) and manipulation (e.g., bending) steps that are more difficult using arrays fabricated
on rigid substrates. Finally, our results demonstrate that these PEI/PVDMA films are able to
withstand exposure to the range of chemical and physical processing conditions used during
MAS and the subsequent hybridization, imaging, and dehybridization of the arrays
(including repeated exposure to concentrated solutions of urea). To our knowledge, this
work represents the first use of polymer multilayers as a solid-phase substrate for the in situ
and multi-step synthesis of complex molecules. With further development, this approach to
surface functionalization could also prove useful for the design of media for the solid-phase
synthesis, characterization, and screening of other macromolecular or small-molecule
agents.
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Figure 1.
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Schematic illustration of the structures, processes, and procedures used to fabricate reactive,
crosslinked polymer multilayers on planar supports as substrates for in situ oligonucleotide
array synthesis. (A) Chemical structures of poly(2-vinyl-4,4-dimethylazlactone) (PVDMA)
and poly(ethylene imine) (PEI). (B) Chemical structures of D-glucamine and 4-amino-1butanol. (C) Schematic of the reactive layer-by-layer film fabrication process. PEI and
PVDMA are deposited sequentially to provide azlactone-functionalized multilayers (D) that
can be readily functionalized post-fabrication by treatment with primary aminefunctionalized nucleophiles (a glucamine-treated film is shown as an example). Films
functionalized to display hydroxyl functionality (D) provide surfaces suitable for the in situ,
base-by-base Maskless Array Synthesis (MAS) (E) of arrays of oligonucleotides.
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Figure 2.
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(A, B) Images of two larger-scale arrays of oligonucleotides, fabricated in the shape of
Bucky Badger, composed of the Probe 2 oligonucleotide sequence and hybridized with Cy3labeled Complement 2 (red) prior to imaging (note: images best viewed in color). The image
in (A) is of an array fabricated on a glucamine-functionalized PEI/PVDMA film; the image
in (B) is of an array fabricated on a 4-amino-1-butanol-functionalized PEI/PVDMA film.
(C) Representative image of oligonucleotide arrays of Probes 1 and 2 arranged in a
checkered pattern (individual array features are 144 × 144 µm) synthesized on a glucaminefunctionalized PEI/PVDMA film fabricated on the surface of a glass substrate. The arrays
were hybridized with fluorescein-labeled Complement 1 (green) and Cy3-labeled
Complement 2 (red) prior to imaging. A line intensity profile for one row of features of the
array is also shown. The intensity values of each feature are the summation of the
fluorescein (green) and Cy3 (red) fluorescence intensities.
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Figure 3.

The stability of each oligonucleotide array was determined by monitoring the fluorescence
intensity of the hybridized features as a function of hybridization cycle. Each array was
hybridized with fluorescently labeled complement (Cy3 fluorescence data shown here), a
fluorescence image was obtained, and then dehybridization was effected using an 8 M urea
solution. The fluorescence values presented are normalized to the initial fluorescence
intensity upon the first hybridization. The fluorescence intensity as a function of
hybridization cycle for an array synthesized on (●) a silanized glass substrate, (■) a
glucamine-treated PEI/PVDMA film fabricated on a glass substrate, and (♦) a glucaminetreated PEI/PVDMA film fabricated on a thin sheet of PET.
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Figure 4.

(A) Representative image of an oligonucleotide array synthesized on a PET sheet coated
with a glucamine-functionalized PEI/PVDMA film (hybridized with fluorescein-labeled
Complement 1 (green) and Cy3-labeled Complement 2 (red) prior to imaging). The dashed
line indicates the region where the array was subsequently cut in half using a razor blade to
produce the smaller substrate fragment shown in (B). (B) This array fragment cut from the
substrate shown in (A) was dehybridized in 8 M urea and then rehybridized prior to
fluorescence imaging (the gray arrow indicates the edge where the larger array was cut).
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Structures of oligonucleotide sequences used in this study.a
Sequence (5’→3’)
Probe 1
Probe 2
Complement 1

Complement 2

a
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Probe oligonucleotides were in situ synthesized directly onto hydroxyl-functionalized substrates (in a 3’ → 5’ direction) using NPPOC-protected
phosphoramidite bases and Maskless Array Synthetic methods. Each probe oligonucleotide was separated from the surface by 10 thymidine (T)
residues. Complementary oligonucleotides were synthesized using standard phosphoramidite chemistry. A fluorescein (F) or Cy3 (3) dye moiety
was attached to the 3’ end of the complement oligonucleotides.
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15330.9 ± 1818.4

23382.5 ± 1196.5

20371.6 ± 1971.5

38688.6 ± 432.4

28405.6 ± 2918.5

28164.9 ± 2073.7

23071.6 ± 2761.4

35523.4 ± 1468.3

Cy3

68

118

94

134

FAM

59

106

81

159

Cy3

signal-to-noise

1.09 ± 0.42

1.18 ± 0.54

1.24 ± 0.72

1.45 ± 0.39

(×1012oligos/cm2)

hybe density

Oligonucleotide arrays were synthesized on glass substrates (silanized glass or glass coated with PEI/PVDMA films treated with 4-amino-1-butanol or D-glucamine). Oligonucleotide arrays, composed of a
checkered pattern of Probe 1 and Probe 2, were synthesized on each substrate. The average fluorescence signal and average signal-to-noise values were determined after hybridization with fluorescently
labeled Complement 1 and 2. The values reported are for n = 3 arrays. The average fluorescence intensity signal was determined by integrating the fluorescence intensity of each feature on the array. The
average background fluorescence intensity, which was used to calculate the signal-to-noise ratio, was determined by integrating the fluorescence intensity of areas on the array that did not contain the
oligonucleotide features. The average signal-to-noise ratio was calculated using Eqn 1. The average hybridization densities were obtained by collecting the hybridized complements in a known volume of 8
M urea and comparing the fluorescence intensity to a calibration curve. Uncertainties shown correspond to the calculated standard error of the mean.

a

Glucamine-treated

Film-Coated PET

Glucamine-treated

Aminobutanol-treated

Film-Coated Glass

Silanized Glass

FAM

fluorescence intensity (RFU)

Characterization of oligonucleotide arrays fabricated on glass substrates.a
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